<DOC>
	<DOCNO>NCT00290394</DOCNO>
	<brief_summary>The purpose study determine effect rosiglitazone normotensive type 2 diabetic patient regard blood-pressure–reducing effect .</brief_summary>
	<brief_title>Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients</brief_title>
	<detailed_description>The first study evaluate effect troglitazone blood pressure human publish recently , demonstrate 5/4 mm Hg reduction ambulatory blood pressure 18 nondiabetic obese subject 12 week ’ treatment . Another study 18 hypertensive subject diabetes mellitus show 18/12 mm Hg decline office blood pressure 8 week treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Blood pressure patient normotensive limit accord JNC VII Diabetes mellitus treat oral antidiabetic diet Any known hypertension , coronary artery disease , congestive hearth failure , renal disease liver disease Antihypertensive treatment</criteria>
	<gender>All</gender>
	<minimum_age>49 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>Blood Pressure ,</keyword>
	<keyword>rosiglitazone , Diabetes Mellitus , Type 2 ,</keyword>
</DOC>